Balaji Amines

NSE: BALAMINESBSE: 530999
Compare with peers
₹ 1,854.10▼ 7.2 (−0.39%)28 Oct, 03:29 pm IST
Market cap
₹ 5,910 Cr.
P/E
29.5x
P/B
3.11x
52-week range
968.1 – 2,629.8
ROE
9%
ROCE
11%
Dividend yield
0.6%
Debt / equity
0.07
Sector
Chemicals & Petrochemicals
Industry
Specialty Chemicals
Listed on
NSE, BSE

About

Balaji Amines Limited is an India-based company, which is engaged in the business of manufacturing of Aliphatic Amines. The Company specializes in manufacturing Methyl Amines, Ethyl Amines, Derivatives of Aliphatic Amines and Specialty Chemicals. The Company's segments include Chemicals and Hotel. It also owns a five-star Hotel in Solapur, Maharashtra. Its products include amines, derivatives, specialty chemicals and pharma excipients. Its amine products include MONOMETHYLAMINE (MMA), DIMETHYLAMINE (DMA), TRIMETHYLAMINE and others. Its specialty chemical products include N-Methyl Pyrrolidone (NMP), Morpholine, 2-PYRROLIDONE, N-ETHYL-2-PYRROLIDONE, GAMMA-BUTYROLACTONE, ACETONITRILE (ACN) and others. Its derivative products include Di-Methyl Acetamide (DMAC); Di-Methyl Amine Hydrochloride (DMA HCL); Tri-Methyl Amine Hydrochloride (TMA HCL), and others. Its pharma excipients products include POLY VINYL PYRROLIDONE(PVP-30) IP/BP/JP GRADE and POLY VINYL PYRROLIDONE(PVP-30)-TECHNICAL GRADE.

Quick check

The five things to look at first. Open one for more.

Compared with its industry

Specialty Chemicals: 130 companies →

Balaji Amines against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.

  • Valuation (P/E)29.5 against a typical 26.3: pricier than most peers (1st = cheapest).72nd of 129
  • Sales growth+27.4% against a typical +25.9% from a year earlier.53rd of 112
  • Profit growth+110.8% against a typical +42.4% from a year earlier.28th of 102
  • Share price, 3 months−18.4% against a typical −5.8%.99th of 118
  • Size₹ 5,909.5 Cr. market value against a typical ₹ 359.6 Cr. (1st = largest).20th of 126

Board meetings

Results dates and other board meetings. Full calendar

Details
2 Nov 2026UpcomingFinancial ResultsBalaji Amines Limited has informed NSE that meeting of the Board of Directors of the Company is Scheduled on 2nd November, 2026, inter alia, to Consider and Approve Un-Audited Standalone and Consolidated Financial Results of the Company for Quarter and Half Year Ended 30th September, 2026
27 Jul 2026Financial ResultsBalaji Amines Limited has informed NSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/ 2026 inter alia, to consider and approve The Un-Audited Standalone and Consolidated Financial Results of the Company for Quarter ended 30th June, 2026
13 May 2026Financial Results/DividendBalaji Amines Ltd-has informed NSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2026 ,inter alia, to consider and approve Audited Standalone and Consolidated Financial Results of the Company for the Quarter and Year ended 31st March, 2026 and to consider and recommend a Final Dividend for FY2025-26, if any.
29 Jan 2026Financial ResultsTo consider and approve the financial results for the period ended December 31, 2025
10 Nov 2025Financial ResultsBalaji Amines Limited has informed NSE that meeting of the Board of Director of the Company is scheduled on 10/11/2025 inter alia, to consider and approve the Un-Audited Standalone and Consolidated Financial Results of the company for the Quarter and Half year ended 30th September, 2025.
2 Aug 2025Financial ResultsTo consider and approve the Financial Results for the period ended Jun 30, 2025
28 May 2025Financial Results/DividendBALAMINES : 28-May-2025 : The Company has informed the Exchange that a Board meeting to be held on May 26, 2025 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on May 28, 2025, To consider and approve the financial results for the period ended March 31, 2025 and dividend

Share price

1Y change +32.13%
Volume (shares)Price (₹)
Close price

Financials

Consolidated figures in ₹ crore.

Quarterly results
₹ Cr.Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales381383414385347313353358341331395456
Expenses327309316319286267293304281275301340
Operating Profit5474986661466055605794116
OPM %14%19%24%17%17%15%17%15%18%17%24%25%
Other Income789898897586
Interest221111111221
Depreciation111112121212131414141414
Profit before tax4870936257415449524686106
Tax %24%21%22%26%27%24%25%25%28%33%25%26%
Net Profit365672464131403737316578
EPS in Rs10.7115.242113.3612.6510.2412.3611.7310.679.719.5123.13

Growth and returns

Compounded yearly rates over each period.

Compounded Sales Growth
10 Years
8%
5 Years
2%
3 Years
−15%
TTM
11%
Compounded Profit Growth
10 Years
11%
5 Years
−7%
3 Years
−20%
TTM
34%
Stock Price CAGR
10 Years
22%
5 Years
−9%
3 Years
0%
TTM
—
Return on Equity
10 Years
18%
5 Years
16%
3 Years
10%
TTM
—

Shareholding

Latest: Jun 2026.

Promoters
54.56%
−0.03 pts in a year
FIIs
3.17%
−1.83 pts in a year
DIIs
1.58%
+0.12 pts in a year
Public
40.69%
+1.73 pts in a year

P/E and EPS over time

Daily P/E and trailing 12-month EPS. EPS updates with each result.

P/E 29.5xEPS (12 months) ₹ 63.00Median P/E 12.8x
P/E (times)EPS (₹)

Peers

Listed companies in the same business.

Peer comparison
Balaji Amines₹ 1,854.10₹ 5,910 Cr.29.5x3.1x9%—
Asian Paints₹ 2,305.00₹ 2,21,095 Cr.58.1x12.1x21.2%12.4%
Solar Industries India₹ 18,320.00₹ 1,65,778 Cr.99.6x26.6x31.4%17.7%
Pidilite Industries₹ 1,514.00₹ 1,54,107 Cr.64.8x14.7x23.8%16.9%
SRF₹ 2,309.00₹ 68,444 Cr.44.6x6.1x13.8%11.6%
Linde India₹ 5,697.00₹ 48,586 Cr.110.5x14.2x13.6%21.7%

Management

Ande Prathap Reddy
Executive Chairman of the Board
Ande Srinivas Reddy
Chief Financial Officer, Whole Time Director
Abhijeet Shailesh Kothadiya
Company Secretary, Compliance Officer
Rajeshwar Reddy Nomula
Managing Director, Whole Time Director
Dundurapu Ram Reddy
Managing Director, Executive Director

Prices are delayed and for information only. Nothing on this page is investment advice.